A Clinical Study to Evaluate the Safety, and Tolerability of BBM-P002 in the Treatment of Parkinson's Disease
Clinical trial NCT07195825 · RECRUITING
Trial details
- NCT number
- NCT07195825
- Sponsor
- Shanghai Xinzhi BioMed Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-27
- Primary completion
- 2027-12-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.